As of the latest close, "McKesson stock price" maintains a strong correlation with pharmaceutical market performance, particularly in generics distribution. On-chain sentiment data shows elevated buying interest. ESCO is trading at $206.97 per share, or 31.4x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free . As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued. "McKesson stock price" benefits from structural healthcare growth and rising demand for biologics. Analysts note long-term tailwinds from federal healthcare programs increasing patient access to specialty drugs.